SBIR/STTR Research Award

Leadless Pacemaker Betavoltaic Power Source

Award identifier f2d8479df454266d2bdd3d3fe18eca0f704bdf90b0a3e375c65e812da46b6e0dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$221,657

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CITY LABS, INC.
Proposal award date
2019-04-01
Contract end date
2019-09-30
UEI
LD55BB3D8EM7
Solicitation number
PA18-574
Topic code
NHLBI

Research abstract

Leadless cardiac pacemakersLCPsrepresent a revolutionary leap forward in cardiac pacing technology via its circumvention of transvenous leadsCurrent LCP lithium CFX batteries arecc resulting in an overallcc LCP deviceThis Phase I effort will demonstrate the feasibility of acc betavoltaic battery for LCPs with ayear lifetimex lifetime of current LCP batteriesenabling LCPs with a volumetric size ofccThis size reduction and increased longevity will allow forimplants over a patient s lifetime with minimal invasive overheadFurthermoreLCPs are currently limited to single chamber pacingrepresenting onlyof the current transvenous implant marketDual chamber and multi chamber leadless pacing also require a size reduction of the LCP to meet the smaller volume space associated with the atriaA betavoltaic battery with acc form factor and a reliableyear life will facilitate mainstream use of LCPs while challenging traditional pacemakersPhase I will demonstrate feasibility via the construction of stackablemicron thick III V betavoltaic cells that utilize a new high beta fluxtritium metal hydride filmPreliminary data shows thatmicrowatts per cctarget power density for acc LCP batterymay be reached if the betavoltaic celli etritium film coupled to the semiconductor cellis thinned down to stackablemicron layersThe work in Phase I will lay the foundation for the design of the stackable cell unit to be developed in Phase IIwhich will result in a battery prototype for testing and integration by a pacemaker corporate partnerThe design will account for electrical parallel stacking of n p and p n cellsI V characteristic behavior from Phasecellspackaging considerationsLCP manufacturer inputand guidelines from regulatory agenciesTritium betavoltaic technology is a solid state power source that does not lose its energy density with volumetric reduction as in the case of lithium batteriesIts principles of operation are similar to a solar cellbut in lieu of photons impinging on the semiconductor cellthe electrons from the radioisotope s beta decay are utilizedSpecific AimDevelop n p and p n wide bandgap diode junctions that are thin and stackableTaskMetalOrganic Chemical Vapour DepositionMOCVDgrowth of n p and p n junctionsTaskThin down substrate and deposit back metalMilestonesCells withmicrons of thicknessDark I V measurements yieldingnanoamps cmatVolts in TasksandVolts in TaskSpecific AimDeposit metal hydride on cell surface to demonstrate thin and stackable betavoltaic cellsTaskDeposit metal hydride junction active area and investigate dark I V properties and loading capacityThe metal hydride will be loaded with a tritium surrogate of protium or deuteriumMilestonesDark I V criteria ofnanoamps cmatVolts and a loading capacity ofor higher by weight of hydrogen to metalThese two specific aims will demonstrate the feasibility of the betavoltaic layers to be stacked in Phase IIresulting in a betavoltaic battery for testing and integration into a revolutionary ultra small LCP with approximately double the lifetime of current batteries The demonstration of high power densityultra small betavoltaic batteries for leadless cardiac pacemakers will enable a new class of medical implants that will demonstrate a paradigm shift in cardiac rhythm managementThis size reduction and increased longevity will extend the benefits of LCPs to a younger patient populationFurthermoreit opens up potential use of LCPs for dual and multi chamber pacing due to the dramatic reduction in battery size

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

15 SBIR/STTR records share this UEI (2018–2025). Reported award amounts total $14,514,384. Reported amounts are not federal obligations.

Phases: Phase II, Phase I, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.